Literature DB >> 19712115

Combined antegrade and retrograde endoscopic retroperitoneal bypass of ureteric strictures: a modification of the 'rendezvous' procedure.

David R Yates1, Sampi S Mehta, Paul A Spencer, Bo T Parys.   

Abstract

OBJECTIVE: To evaluate our experience of treating complicated iatrogenic ureteric strictures with a combined antegrade and retrograde endoscopic retroperitoneal bypass technique, a modification of the so-called 'rendezvous' procedure. PATIENTS AND METHODS: Seven patients presented to our institution between 2004 and 2008 after developing a complicated iatrogenic ureteric stricture, impassable with solitary antegrade or retrograde stenting techniques. In most cases there was a significant loss of ureteric continuity, with some strictures of up to 10-12 cm. After initial temporizing management with a percutaneous nephrostomy, each patient had a radiological 'rendezvous' procedure to insert a JJ stent and restore ureteric continuity. After 6 months, the JJ stents were removed and the patients evaluated by symptom assessment, serial measurements of serum creatinine and diuretic renography (F-15 mercaptoacetyl triglycine).
RESULTS: All seven 'rendezvous' procedures were successful and a ureteric stent was inserted across or around the stricture in all cases. Five of seven patients whose follow-up was >6 months had their stent removed successfully. At a median follow-up of 21 months, all patients are alive and none has required subsequent surgery. Six of the seven patients presented with significant symptoms and they are all currently symptom-free, which we consider to be a successful clinical outcome. No patient has developed significant renal impairment (estimated glomerular filtration rate (<30 mL/min) but we could only confirm successful unequivocal renographic drainage in one patient.
CONCLUSION: Combining antegrade radiological and retrograde endourological techniques, it is possible to restore ureteric continuity with a JJ stent, even in situations with extensive loss of the ureteric lumen. This reduces the need for morbid open surgical repair and offers a long-term solution to patients who might otherwise be consigned to less favourable conservative measures.

Entities:  

Mesh:

Year:  2009        PMID: 19712115     DOI: 10.1111/j.1464-410X.2009.08807.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  6 in total

Review 1.  Interventional radiology in iatrogenic ureteral leaks: case series and literature review.

Authors:  Claudia Trombatore; Giuseppe Giordano; Vincenzo Magnano San Lio
Journal:  Radiol Med       Date:  2017-05-16       Impact factor: 3.469

2.  Endoscopic realignment in the management of complete transected ureter.

Authors:  Chunlai Liu; Xiling Zhang; Dongwei Xue; Yili Liu; Ping Wang
Journal:  Int Urol Nephrol       Date:  2013-08-08       Impact factor: 2.370

3.  Partial substitution of the ureter using a double short segments of the ileum following the Monti procedure.

Authors:  Mounir Lahyani; Nabil Jakhlal; Fouad Bakloul; Tarik Karmouni; Khalid Elkhader; Abdellatif Koutani; Ahmed Ibn Attya Andaloussi; Ismail Bezza; Mohamed Elouazni; Lhssan Ifrine; Abdelkader Belkouchi
Journal:  Pan Afr Med J       Date:  2015-03-19

4.  Image-guided ureteral reconstruction using rendezvous technique for complex ureteric transection after gunshot injuries.

Authors:  Mohammad Arabi; Abdulaziz Mat'hami; Mohammad T Said; Muhammad Bulbul; Maurice Haddad; Aghiad Al-Kutoubi
Journal:  Avicenna J Med       Date:  2016 Jan-Mar

5.  Minimally invasive surgical treatment on delayed uretero-vaginal fistula.

Authors:  Xinying Li; Ping Wang; Yili Liu; Chunlai Liu
Journal:  BMC Urol       Date:  2018-10-29       Impact factor: 2.264

6.  Long-segmental ureteral reconstruction using tubularization of ileal seromuscular fold: experimental canine study and preliminary clinical experience.

Authors:  Qi Chen; Lujia Zou; Rongzong Liu; Shanhua Mao; Yun Hu; Chenyang Xu; Haowen Jiang
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.